Skip to search formSkip to main contentSkip to account menu

Trumenba

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Background: In February 2015, two unlinked culture-confirmed cases of Neisseria meningitidis serogroup B (MenB) disease occurred… 
2017
2017
In response to a university-based serogroup B meningococcal disease outbreak, the serogroup B meningococcal vaccine Trumenba was… 
2017
2017
ABSTRACT Neisseria meningitidis is a major cause of bacterial meningitis and sepsis worldwide. Capsular polysaccharide vaccines… 
2016
2016
Trumenba (bivalent rLP2086) is a vaccine licensed for the prevention of meningococcal meningitis disease caused by Neisseria… 
Review
2015
Review
2015
Summary Immunisation against meningococcal meningitis has a long history, which has passed through several phases: the studies by…